Novo Nordisk announced phase 1b/2a clinical trial results for amycretin this morning. Patients taking the GLP-1 drug lost an average of 9.7% of their weight in 36 weeks. This is the best news Novo ...

Dr. Lisa Dahlgren discusses her study on the effect human touch has on our health and wellbeing. Video by Ellenoor Shameli. Filming by Darryl Laiu. Nine-time Oscar nominee Robert De Niro offers ...

Competition from Him & Hers Health seems to be weighing on Novo Nordisk's stock. A half-hearted rating from Morgan Stanley yesterday isn't cheering investors up very much at all. Yet a new study ...

Novo Nordisk is opening a new front in its fight against sickle cell disease, inking a deal with IMMvention Therapeutix to co-develop oral treatments for the red blood cell disorder and other ...

Novo Nordisk has reported 22% weight loss in people who received weekly amycretin injections for 36 weeks, triggering an 11% jump in the Danish drugmaker’s share price in premarket trading.

The SE01 humanoid robot, which previously made headlines for achieving one of the most human-like gaits, has again captured global attention. Chinese robotics firm EngineAI has posted a new video ...

Discoveries in the past two decades have added new branches to the human family tree, including species such as the hobbit-like Homo floresiensis and the powerfully built Homo naledi. A pinkie ...

According to a press release from China’s Beijing Economic-Technological Development Area, more than 12,000 human runners will square off against dozens of bipedal, humanoid robots from more ...

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it gave to pharmacy firms, obesity charities and other professional bodies ...

Feb. 11, 2025 — A new study has discovered in mouse models that genes associated with repairing mismatched DNA are critical in eliciting damages to neurons that are ... 'Junk' RNA Segments Play ...

“If you think about what we might expect humans to accomplish in an area like biology in 100 years, I think a doubling of the human lifespan is not at all crazy,” he said yesterday (Jan ...

Novo Nordisk A/S rose the most since August 2023 after its experimental shot delivered as much as 22% weight loss in an early-stage trial, boosting investors’ hopes for the drugmaker’s pipeline.